Table 1—

Demographic and disease characteristics at baseline

Placebo20 mg rimonabant
n140138
Age (years)55.5 ± 10.457.8 ± 10.5
Male sex46.452.9
Race
    White84.384.1
    Black3.62.2
    Asian/Oriental0.71.4
    Other11.412.3
Body weight (kg)96.3 ± 21.096.6 ± 21.1
BMI (kg/m2)34.6 ± 6.934.4 ± 6.6
    >2789.389.9
    ≥3072.972.5
Waist circumference (cm)108.8 ± 14.8108.7 ± 13.6
    High waist circumference (% men/% women)*70.8/88.066.7/90.8
Diabetes duration (months)15.1 ± 13.416.0 ± 11.2
Family history of type 2 diabetes52.146.4
    A1C (%)7.9 ± 0.77.9 ± 0.8
    A1C ≥8.5 and ≤1025.725.4
FPG (mmol/l)8.7 ± 1.99.0 ± 1.9
Concomitant antidyslipidemia medication35.729.7
Concomitant antihypertensive medication67.162.3
  • Data are means ± SD or %.

  • *

    * Waist circumference >102 cm (men) or >88 cm (women).